Kim et al. found that only 10% of basal cell carcinomas (BCCs) showed strong immunoreactivity for CRH, whereas squamous cell carcinoma (SCC) showed strong expression in 70% and malignant melanoma in 80% of cases [6]. Here, CRH is linked to melanoma.